HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Collodion baby and loricrin keratoderma: a case report and mutation analysis.

Abstract
Hereditary palmoplantar keratodermas (PPK) comprise a clinically and genetically heterogeneous group of genodermatoses, which share the characteristic of impaired epidermal differentiation, resulting in prominent palmoplantar hyperkeratosis. Molecular genetic analyses have helped characterize the underlying genetic defects in an increasing number of hereditary PPKs over the past two decades, and thus a pathophysiological classificaiton seems more reasonable. Today PPK can be classified based on defects in keratins, loricrin, desmosomes, connexins and cathepsins. In this report, we describe a 22-year-old man who had been born a collodion baby, and later developed diffuse PPK with pseudoainhum and generalized ichthyosis. His mother and grandmother had similar characteristics. Direct sequencing of genomic DNA identified a frameshift insertion mutation (730insG) in the loricrin gene. This family had the typical presentation of loricrin keratoderma. It also indicates that collodion baby may be the first presentation in patients with loricrin keratoderma.
AuthorsJ M Yeh, M H Yang, S C Chao
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 38 Issue 2 Pg. 147-50 (Mar 2013) ISSN: 1365-2230 [Electronic] England
PMID22831754 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© The Author(s). CED © 2012 British Association of Dermatologists.
Chemical References
  • Membrane Proteins
  • loricrin
Topics
  • Humans
  • Ichthyosiform Erythroderma, Congenital (genetics)
  • Keratoderma, Palmoplantar (genetics)
  • Male
  • Membrane Proteins (genetics)
  • Mutation
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: